CompletedNot applicableNCT03548805

Ologen® Collagen Matrix Versus Mitomycin-C in Patients With Juvenile-onset Open Angle Glaucoma

Studying NON RARE IN EUROPE: Primary adult open-angle glaucoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
L.V. Prasad Eye Institute
Principal Investigator
Senthil Sirisha, MS
YES
Intervention
ologen® Collagen Matrix(procedure)
Enrollment
30 enrolled
Eligibility
10-40 years · All sexes
Timeline
20182023

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03548805 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Primary adult open-angle glaucoma

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Primary adult open-angle glaucoma

← Back to all trials